Home > Drug Search >
  • company_query: Arbutus
  •   > 
Drug Filter
Category:
chemistry (16) biology (7)
Status:
Approved (1) Phase Ⅲ (3) Phase Ⅱ (9) Phase Ⅰ (10)
Clinical Stage:
Pending (5) Active (14) Discontinued (3)
Bio-Type:
Vaccine (2) Recombinant enzyme (2) Recombinant cytokines (1)
Indication:
Acute coronary syndrome (ACS) (1) Atopic dermatitis (1) Chemotherapy-induced nausea and vomiting (1) Follicular lymphoma (1) Fragile X syndrome (1) Pancreatitis (1) HBV infection (3) Heart failure (1) Idiopathic thrombocytopenic purpura (ITP) (1) Insomnia (1) Rabies (1) Melanoma (1) Moderate-to-severe acute pain (1) Vascular disorders (1) Non-Hodgkin’s lymphoma (NHL) (1) Osteoarthritis (OA) (3) Osteoporosis (1) Percutaneous coronary intervention (PCI) (1) Perennial allergic rhinitis (1) Postoperative nausea and vomiting (1) Rheumatoid arthritis (RA) (1) Seasonal allergic rhinitis (1) Sedation (1) Solid tumours (2) Systemic lupus erythematosus (1) Type 2 diabetes (1) Pain (1) Acute pain (1) Anesthesia (1) Allergic asthma (1) Angelman syndrome (1) Diffuse large B cell lymphoma (1) Cardiovascular disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top